Diabetes Therapy
New peptide from Squalus mitsukurii liver shows antidiabetic properties in mice
Published in Obesity and Diabetes Week, February 20th, 2006
According to recent research published in the Journal of Pharmacy and Pharmacology, "We have evaluated the antidiabetic effect of S-8300 (a peptide extracted from shark liver (Squalus mitsukurii)) in streptozocin (streptozotocin)-diabetic mice."
F.J. Huang and colleagues working with the China Pharmaceutical University described, "Diabetes was induced by a single intravenous injection of streptozocin (150 mg/kg1). The effects of S-8300 (3 or 10 mg/kg1) on diabetic mice were investigated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Rise in insulin resistance after C18:1 trans-fatty acid enriched meal depends on FABP2 gene - Diabetes Therapy
Two-day VLED lowered fasting plasma glucose in obese type 2 diabetics on insulin therapy - Obesity Pathogenesis
Capsaicin-induced sensory desensitization improves glucose tolerance in obese Zucker rats - Obesity Pathogenesis
Healthy lifestyle prevents obesity and hyperglycemia, which can improve mental health - Antithrombosis
Adiponectin is an endogenous antithrombotic factor - Atherosclerosis
Fatty acids cause alterations of hASMC proteoglycans that increase affinity for LDL - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
